Skip to content
PICO Portalanswers from OpenAlex

Effect of hypertension on long-term adverse clinical outcomes and liver fibrosis progression in MASLD

PaperCitations, authors & open-access status

Effect of hypertension on long-term adverse clinical outcomes and liver fibrosis progression in MASLD is a paper indexed in PICO Portal from OpenAlex.

How many citations does Effect of hypertension on long-term adverse clinical outcomes and liver fibrosis progression in MASLD have?

PICO Portalcitation count

Effect of hypertension on long-term adverse clinical outcomes and liver fibrosis progression in MASLD has 42 citations in the OpenAlex counts PICO Portal stores.

When was Effect of hypertension on long-term adverse clinical outcomes and liver fibrosis progression in MASLD published?

PICO Portalyear

Effect of hypertension on long-term adverse clinical outcomes and liver fibrosis progression in MASLD has 2025 year in the PICO Portal index.

What is the open-access status of Effect of hypertension on long-term adverse clinical outcomes and liver fibrosis progression in MASLD?

PICO Portaloa status

Effect of hypertension on long-term adverse clinical outcomes and liver fibrosis progression in MASLD has closed oa status in the PICO Portal index.

What is the DOI of Effect of hypertension on long-term adverse clinical outcomes and liver fibrosis progression in MASLD?

PICO Portaldoi

The DOI for Effect of hypertension on long-term adverse clinical outcomes and liver fibrosis progression in MASLD is on the source record.

What is the PMID of Effect of hypertension on long-term adverse clinical outcomes and liver fibrosis progression in MASLD?

PICO Portalpmid

The PMID for Effect of hypertension on long-term adverse clinical outcomes and liver fibrosis progression in MASLD is on the source record.

What is the OpenAlex record for Effect of hypertension on long-term adverse clinical outcomes and liver fibrosis progression in MASLD?

PICO Portalopenalex

The OpenAlex for Effect of hypertension on long-term adverse clinical outcomes and liver fibrosis progression in MASLD is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial